Cargando…

Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes

OBJECTIVE: Ashkenazi‐Jewish (AJ) population‐based BRCA testing is acceptable, cost‐effective and amplifies primary prevention for breast & ovarian cancer. However, data describing lifestyle impact are lacking. We report long‐term results of population‐based BRCA testing on lifestyle behaviour an...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnell, Matthew, Gaba, Faiza, Sobocan, Monika, Desai, Rakshit, Sanderson, Saskia, Loggenberg, Kelly, Gessler, Sue, Side, Lucy, Brady, Angela F., Dorkins, Huw, Wallis, Yvonne, Jacobs, Chris, Legood, Rosa, Beller, Uziel, Tomlinson, Ian, Wardle, Jane, Menon, Usha, Jacobs, Ian, Manchanda, Ranjit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796935/
https://www.ncbi.nlm.nih.gov/pubmed/35781768
http://dx.doi.org/10.1111/1471-0528.17253
_version_ 1784860603768111104
author Burnell, Matthew
Gaba, Faiza
Sobocan, Monika
Desai, Rakshit
Sanderson, Saskia
Loggenberg, Kelly
Gessler, Sue
Side, Lucy
Brady, Angela F.
Dorkins, Huw
Wallis, Yvonne
Jacobs, Chris
Legood, Rosa
Beller, Uziel
Tomlinson, Ian
Wardle, Jane
Menon, Usha
Jacobs, Ian
Manchanda, Ranjit
author_facet Burnell, Matthew
Gaba, Faiza
Sobocan, Monika
Desai, Rakshit
Sanderson, Saskia
Loggenberg, Kelly
Gessler, Sue
Side, Lucy
Brady, Angela F.
Dorkins, Huw
Wallis, Yvonne
Jacobs, Chris
Legood, Rosa
Beller, Uziel
Tomlinson, Ian
Wardle, Jane
Menon, Usha
Jacobs, Ian
Manchanda, Ranjit
author_sort Burnell, Matthew
collection PubMed
description OBJECTIVE: Ashkenazi‐Jewish (AJ) population‐based BRCA testing is acceptable, cost‐effective and amplifies primary prevention for breast & ovarian cancer. However, data describing lifestyle impact are lacking. We report long‐term results of population‐based BRCA testing on lifestyle behaviour and cancer risk perception. DESIGN: Two‐arm randomised controlled trials (ISRCTN73338115, GCaPPS): (a) population‐screening (PS); (b) family history (FH)/clinical criteria testing. SETTING: North London AJ‐population. POPULATION/SAMPLE: AJ women/men >18 years. Exclusions: prior BRCA testing or first‐degree relatives of BRCA‐carriers. METHODS: Participants were recruited through self‐referral. All participants received informed pre‐test genetic counselling. The intervention included genetic testing for three AJ BRCA‐mutations: 185delAG(c.68_69delAG), 5382insC(c.5266dupC) and 6174delT(c.5946delT). This was undertaken for all participants in the PS arm and participants fulfilling FH/clinical criteria in the FH arm. Patients filled out customised/validated questionnaires at baseline/1‐year/2‐year/3‐year follow‐ups. Generalised linear‐mixed models adjusted for covariates and appropriate contrast tests were used for between‐group/within‐group analysis of lifestyle and behavioural outcomes along with evaluating factors associated with these outcomes. Outcomes are adjusted for multiple testing (Bonferroni method), with P < 0.0039 considered significant. OUTCOME MEASURES: Lifestyle/behavioural outcomes at baseline/1‐year/2‐year/3‐year follow‐ups. RESULTS: 1034 participants were randomised to PS (n = 530) or FH (n = 504) arms. No significant difference was identified between PS‐ and FH‐based BRCA testing approaches in terms of dietary fruit/vegetable/meat consumption, vitamin intake, alcohol quantity/ frequency, smoking behaviour (frequency/cessation), physical activity/exercise or routine breast mammogram screening behaviour, with outcomes not affected by BRCA test result. Cancer risk perception decreased with time following BRCA testing, with no difference between FH/PS approaches, and the perception of risk was lowest in BRCA‐negative participants. Men consumed fewer fruits/vegetables/vitamins and more meat/alcohol than women (P < 0.001). CONCLUSION: Population‐based and FH‐based AJ BRCA testing have similar long‐term lifestyle impacts on smoking, alcohol, dietary fruit/vegetable/meat/vitamin, exercise, breast screening participation and reduced cancer risk perception.
format Online
Article
Text
id pubmed-9796935
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-97969352023-01-04 Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes Burnell, Matthew Gaba, Faiza Sobocan, Monika Desai, Rakshit Sanderson, Saskia Loggenberg, Kelly Gessler, Sue Side, Lucy Brady, Angela F. Dorkins, Huw Wallis, Yvonne Jacobs, Chris Legood, Rosa Beller, Uziel Tomlinson, Ian Wardle, Jane Menon, Usha Jacobs, Ian Manchanda, Ranjit BJOG Randomised Controlled Trial OBJECTIVE: Ashkenazi‐Jewish (AJ) population‐based BRCA testing is acceptable, cost‐effective and amplifies primary prevention for breast & ovarian cancer. However, data describing lifestyle impact are lacking. We report long‐term results of population‐based BRCA testing on lifestyle behaviour and cancer risk perception. DESIGN: Two‐arm randomised controlled trials (ISRCTN73338115, GCaPPS): (a) population‐screening (PS); (b) family history (FH)/clinical criteria testing. SETTING: North London AJ‐population. POPULATION/SAMPLE: AJ women/men >18 years. Exclusions: prior BRCA testing or first‐degree relatives of BRCA‐carriers. METHODS: Participants were recruited through self‐referral. All participants received informed pre‐test genetic counselling. The intervention included genetic testing for three AJ BRCA‐mutations: 185delAG(c.68_69delAG), 5382insC(c.5266dupC) and 6174delT(c.5946delT). This was undertaken for all participants in the PS arm and participants fulfilling FH/clinical criteria in the FH arm. Patients filled out customised/validated questionnaires at baseline/1‐year/2‐year/3‐year follow‐ups. Generalised linear‐mixed models adjusted for covariates and appropriate contrast tests were used for between‐group/within‐group analysis of lifestyle and behavioural outcomes along with evaluating factors associated with these outcomes. Outcomes are adjusted for multiple testing (Bonferroni method), with P < 0.0039 considered significant. OUTCOME MEASURES: Lifestyle/behavioural outcomes at baseline/1‐year/2‐year/3‐year follow‐ups. RESULTS: 1034 participants were randomised to PS (n = 530) or FH (n = 504) arms. No significant difference was identified between PS‐ and FH‐based BRCA testing approaches in terms of dietary fruit/vegetable/meat consumption, vitamin intake, alcohol quantity/ frequency, smoking behaviour (frequency/cessation), physical activity/exercise or routine breast mammogram screening behaviour, with outcomes not affected by BRCA test result. Cancer risk perception decreased with time following BRCA testing, with no difference between FH/PS approaches, and the perception of risk was lowest in BRCA‐negative participants. Men consumed fewer fruits/vegetables/vitamins and more meat/alcohol than women (P < 0.001). CONCLUSION: Population‐based and FH‐based AJ BRCA testing have similar long‐term lifestyle impacts on smoking, alcohol, dietary fruit/vegetable/meat/vitamin, exercise, breast screening participation and reduced cancer risk perception. John Wiley and Sons Inc. 2022-07-13 2022-11 /pmc/articles/PMC9796935/ /pubmed/35781768 http://dx.doi.org/10.1111/1471-0528.17253 Text en © 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Randomised Controlled Trial
Burnell, Matthew
Gaba, Faiza
Sobocan, Monika
Desai, Rakshit
Sanderson, Saskia
Loggenberg, Kelly
Gessler, Sue
Side, Lucy
Brady, Angela F.
Dorkins, Huw
Wallis, Yvonne
Jacobs, Chris
Legood, Rosa
Beller, Uziel
Tomlinson, Ian
Wardle, Jane
Menon, Usha
Jacobs, Ian
Manchanda, Ranjit
Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
title Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
title_full Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
title_fullStr Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
title_full_unstemmed Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
title_short Randomised trial of population‐based BRCA testing in Ashkenazi Jews: long‐term secondary lifestyle behavioural outcomes
title_sort randomised trial of population‐based brca testing in ashkenazi jews: long‐term secondary lifestyle behavioural outcomes
topic Randomised Controlled Trial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796935/
https://www.ncbi.nlm.nih.gov/pubmed/35781768
http://dx.doi.org/10.1111/1471-0528.17253
work_keys_str_mv AT burnellmatthew randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT gabafaiza randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT sobocanmonika randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT desairakshit randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT sandersonsaskia randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT loggenbergkelly randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT gesslersue randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT sidelucy randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT bradyangelaf randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT dorkinshuw randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT wallisyvonne randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT jacobschris randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT legoodrosa randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT belleruziel randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT tomlinsonian randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT wardlejane randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT menonusha randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT jacobsian randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes
AT manchandaranjit randomisedtrialofpopulationbasedbrcatestinginashkenazijewslongtermsecondarylifestylebehaviouraloutcomes